Ping An Biomedical PASW
NASDAQ PASW
$0.13 0.00 (-0.81%)
At close: Aug 21, 2026 · 4:00 PM EDT

Ping An Biomedical (PASW) Cash & Equivalents (2024 - 2025)

Ping An Biomedical's (PASW) quarterly Cash & Equivalents came in at $163816.4 in Q3 2025, up 796.76% YoY from $18267.7 in Q3 2024, and up 807.97% on a QoQ basis from $18042.0 in Q1 2025.

Ping An Biomedical (PASW) Cash & Equivalents (2024 - 2025) Analysis & Trends

Ping An Biomedical (PASW) has 2 years of Cash & Equivalents data on file, last reported at $163816.4 in Q3 2025.

  • Quarterly Cash & Equivalents rose 796.76% year-over-year to $163816.4 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $163816.4 (up 796.76% YoY) and the FY2025 annual result came in at $164697.0, up 801.58% from the prior year.
  • Cash & Equivalents climbed to $163816.4 in Q3 2025, from $18042.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $163816.4 in Q3 2025 to a low of $18042.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Albany International 1.68 Bn 1.60 Bn 107.90 Mn 77.35 Mn
2 SMJ International Holdings 292.82 Mn 273.18 Mn - 11.45 Mn
3 Unifi 148.39 Mn 119.92 Mn 9.12 Mn 26.56 Mn
4 Culp 42.82 Mn 42.82 Mn - 8.27 Mn
5 Ping An Biomedical 2.51 Mn -2.61 Mn - 163,816.43

Historic Data

Download Data
DateValue
Sep 30, 2025 163,816.43
Mar 31, 2025 18,042.00
Sep 30, 2024 18,267.66